Kymera Therapeutic
-$0.07 (-0.12%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KYMR and other ETFs, options, and stocks.
About KYMR
Kymera Therapeutics, Inc. operates as a biotechnology company, which engages in curing untreatable diseases. It focuses on discovering and developing novel small molecule therapeutics.
CEO
Nello Mainolfi
Employees
75
Headquarters
Watertown, Massachusetts
Founded
2015
KYMR Key Statistics
Market Cap
2.92B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
282.09K
High Today
$58.97
Low Today
$56.96
Open Price
$58.13
Volume
168.74K
52 Week High
$91.92
52 Week Low
$29.93
Analyst Ratings
80%
of 10 ratings
Buy
80%
Hold
20%
Sell
0%
KYMR Earnings
-$0.55
-$0.37
-$0.18
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 5, Pre-Market